Susceptibility of Pseudomonas pseudomallei to new β-lactam and aminoglycoside antibiotics
- 1 February 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 21 (2) , 171-175
- https://doi.org/10.1093/jac/21.2.171
Abstract
Pseudomonas pseudomallei is resistant to many antimicrobial agents. We determined the susceptibility to twelve β-lactams and six aminoglycosides of twelve isolates of P. pseudomallei. Imipenem (MIC range 0·5-1·0 mg/l; MIC90 10 mg/l), ceftazidime (MIC range 1–8 mg/l; MIC90 8·0 mg/l), amoxycillin/clavulanate (MIC range 4–8 mg/l; MIC90 8·0 mg/l), piperacillin (MIC range 4–16 mg/l; MIC90 8·0 mg/l), and carumonam (MIC range 4–;16 mg/l; MIC90 8·0 mg/l) were the most active. Aminoglycosides were relatively inactive, for example, gentamicin (MIC range 16–64 mg/l; MIC90 64 mg/l), netilmicin (MIC range 16–128 mg/l; MIC90 128 mg/l) and amikacin (MIC range 32–64 mg/l; MIC90 64 mg/l).Keywords
This publication has 6 references indexed in Scilit:
- Imipenem: First of a New Class of Beta-Lactam AntibioticsAnnals of Internal Medicine, 1985
- Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophiliaAntimicrobial Agents and Chemotherapy, 1982
- Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stabilityAntimicrobial Agents and Chemotherapy, 1982
- Identification of Pseudomonas pseudomallei in the clinical laboratory.Journal of Clinical Pathology, 1979
- Treatment of Pulmonary Melioidosis with Combination of Trimethoprim and SulfamethoxazoleChest, 1978
- TRIMETHOPRIM-SULFAMETHOXAZOLE THERAPY OF PULMONARY MELIOIDOSISPublished by Elsevier ,1976